AU2011900149A0 - Use of Naltrexone for Treating Alzheimers Disease - Google Patents

Use of Naltrexone for Treating Alzheimers Disease

Info

Publication number
AU2011900149A0
AU2011900149A0 AU2011900149A AU2011900149A AU2011900149A0 AU 2011900149 A0 AU2011900149 A0 AU 2011900149A0 AU 2011900149 A AU2011900149 A AU 2011900149A AU 2011900149 A AU2011900149 A AU 2011900149A AU 2011900149 A0 AU2011900149 A0 AU 2011900149A0
Authority
AU
Australia
Prior art keywords
naltrexone
alzheimers disease
treating alzheimers
treating
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2011900149A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Edith Cowan University
Original Assignee
Edith Cowan University
Filing date
Publication date
Application filed by Edith Cowan University filed Critical Edith Cowan University
Publication of AU2011900149A0 publication Critical patent/AU2011900149A0/en
Abandoned legal-status Critical Current

Links

AU2011900149A 2011-01-18 Use of Naltrexone for Treating Alzheimers Disease Abandoned AU2011900149A0 (en)

Publications (1)

Publication Number Publication Date
AU2011900149A0 true AU2011900149A0 (en) 2011-02-03

Family

ID=

Similar Documents

Publication Publication Date Title
IL228738A0 (en) Antibodies for treatment of cancer
HK1201256A1 (en) Pyrrolopyrimidine compounds for the treatment of cancer
AP3544A (en) Compounds for the treatment of addiction
EP2675458A4 (en) Compounds and methods for treatment of hypertension
KG1376C1 (en) Method for keratoconus treatment
HK1200096A1 (en) Methods for treating intrapulmonary infections
HK1201771A1 (en) Compositions and methods for treating alzheimers disease
HK1199261A1 (en) Methods for treatment of diseases
EP2994460A4 (en) Compounds for treatment of angiogenesis-mediated diseases
SG2014014724A (en) METHODS FOR THE TREATMENT OF IL-1ß RELATED CONDITIONS
HK1185874A1 (en) Novel 4-amino-n-hydroxy-benzamides for the treatment of cancer 4--n--
EP2852403A4 (en) Methods for modification of tissues
EP2544686A4 (en) Combination methods for treatment of disease
IL230479A0 (en) Method for treating cancer by combined use of drugs
EP2701702A4 (en) Oxymetazoline for the treatment of ano-rectal disorders
WO2011137376A9 (en) Compounds for anti-fungal treatment
AU2011900149A0 (en) Use of Naltrexone for Treating Alzheimers Disease
AU2010900030A0 (en) Use of Naltrexone for Treating Alzheimers Disease
AU2011905428A0 (en) Treatment of Hydrocarbons
GB201106981D0 (en) Compounds for the treatment of clostridium difficle-associated disease
AU2011901436A0 (en) Methods of treatment
IL228973A0 (en) Oxymetazoline for the treatment of ano-rectal disorders
AU2011902655A0 (en) Methods of treating or preventing rheumatic disease
GB201119533D0 (en) Compounds for the treatment of neoplasia
GB201105302D0 (en) Treatment of acidosis